However, we just used public databases of Oncomine, Kaplan–Meier plotter, GEO, PrognoScan, TCGA, TISIDB, and LinkedOmics datasets to demonstrate the effects of MYL5 on prognosis and immune infiltration in breast tumors. The gene discussed is MYL5; the disease is breast neoplasm.